A novel compound active against SARS-CoV-2 targeting uridylate-specific endoribonuclease (NendoU/NSP15):
in silico
and
in vitro
investigations
RSC Medicinal Chemistry | August 18, 2021 | Volume: 12 | Issue: 10 | Pages: 1757-1764
10.1039/d1md00202c
| PMID 34778776
A novel hydroxyethylamine compound was synthesised that displayed biological potency against SARS-CoV-2.